- call +1-201-465-4211
- email sales@mrinsights.biz
Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
Scope of the Report:
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
The worldwide market for Hadron Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Hadron Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Koninklijke Philips N.V.
Advanced Oncotherapy
Varian Medical Systems, Inc.
Optivus Proton Therapy, Inc.
Hitachi, Ltd.
Mevion Medical Systems
ProTom International
Mitsubishi Electric Corporation
Sumitomo Corporation
ProNova Solutions, LLC
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Electron Beam
Proton Beam
Neutron Beam
Carbon Ion Beam
Alpha Particle Beam
Beta Particle Beam
Market Segment by Applications, can be divided into
Pediatric Cancer
Bone and Soft Tissue Cancer
Prostate Cancer
Lung Cancer
Liver Cancer
Eye Cancer
Head & Neck Cancer
Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
There are 15 Chapters to deeply display the global Hadron Therapy market.
Chapter 1, to describe Hadron Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hadron Therapy, with sales, revenue, and price of Hadron Therapy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hadron Therapy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hadron Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hadron Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Hadron Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Electron Beam
1.2.2 Proton Beam
1.2.3 Neutron Beam
1.2.4 Carbon Ion Beam
1.2.5 Alpha Particle Beam
1.2.6 Beta Particle Beam
1.3 Market Analysis by Applications
1.3.1 Pediatric Cancer
1.3.2 Bone and Soft Tissue Cancer
1.3.3 Prostate Cancer
1.3.4 Lung Cancer
1.3.5 Liver Cancer
1.3.6 Eye Cancer
1.3.7 Head & Neck Cancer
1.3.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Koninklijke Philips N.V.
2.1.1 Business Overview
2.1.2 Hadron Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Koninklijke Philips N.V. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Advanced Oncotherapy
2.2.1 Business Overview
2.2.2 Hadron Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Advanced Oncotherapy Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Varian Medical Systems, Inc.
2.3.1 Business Overview
2.3.2 Hadron Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Varian Medical Systems, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Optivus Proton Therapy, Inc.
2.4.1 Business Overview
2.4.2 Hadron Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Optivus Proton Therapy, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hitachi, Ltd.
2.5.1 Business Overview
2.5.2 Hadron Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hitachi, Ltd. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mevion Medical Systems
2.6.1 Business Overview
2.6.2 Hadron Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mevion Medical Systems Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 ProTom International
2.7.1 Business Overview
2.7.2 Hadron Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ProTom International Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mitsubishi Electric Corporation
2.8.1 Business Overview
2.8.2 Hadron Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mitsubishi Electric Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sumitomo Corporation
2.9.1 Business Overview
2.9.2 Hadron Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sumitomo Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 ProNova Solutions, LLC
2.10.1 Business Overview
2.10.2 Hadron Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ProNova Solutions, LLC Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hadron Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Hadron Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hadron Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hadron Therapy Manufacturer Market Share in 2017
3.3.2 Top 6 Hadron Therapy Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Hadron Therapy Market Analysis by Regions
4.1 Global Hadron Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Hadron Therapy Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hadron Therapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Hadron Therapy Sales and Growth Rate (2013-2018)
4.3 Europe Hadron Therapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hadron Therapy Sales and Growth Rate (2013-2018)
4.5 South America Hadron Therapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hadron Therapy Sales and Growth Rate (2013-2018)
5 North America Hadron Therapy by Countries
5.1 North America Hadron Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Hadron Therapy Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hadron Therapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Hadron Therapy Sales and Growth Rate (2013-2018)
5.3 Canada Hadron Therapy Sales and Growth Rate (2013-2018)
5.4 Mexico Hadron Therapy Sales and Growth Rate (2013-2018)
6 Europe Hadron Therapy by Countries
6.1 Europe Hadron Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Hadron Therapy Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hadron Therapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hadron Therapy Sales and Growth Rate (2013-2018)
6.3 UK Hadron Therapy Sales and Growth Rate (2013-2018)
6.4 France Hadron Therapy Sales and Growth Rate (2013-2018)
6.5 Russia Hadron Therapy Sales and Growth Rate (2013-2018)
6.6 Italy Hadron Therapy Sales and Growth Rate (2013-2018)
7 Asia-Pacific Hadron Therapy by Countries
7.1 Asia-Pacific Hadron Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hadron Therapy Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hadron Therapy Revenue and Market Share by Countries (2013-2018)
7.2 China Hadron Therapy Sales and Growth Rate (2013-2018)
7.3 Japan Hadron Therapy Sales and Growth Rate (2013-2018)
7.4 Korea Hadron Therapy Sales and Growth Rate (2013-2018)
7.5 India Hadron Therapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hadron Therapy Sales and Growth Rate (2013-2018)
8 South America Hadron Therapy by Countries
8.1 South America Hadron Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Hadron Therapy Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hadron Therapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hadron Therapy Sales and Growth Rate (2013-2018)
8.3 Argentina Hadron Therapy Sales and Growth Rate (2013-2018)
8.4 Colombia Hadron Therapy Sales and Growth Rate (2013-2018)
9 Middle East and Africa Hadron Therapy by Countries
9.1 Middle East and Africa Hadron Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hadron Therapy Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hadron Therapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hadron Therapy Sales and Growth Rate (2013-2018)
9.3 UAE Hadron Therapy Sales and Growth Rate (2013-2018)
9.4 Egypt Hadron Therapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Hadron Therapy Sales and Growth Rate (2013-2018)
9.6 South Africa Hadron Therapy Sales and Growth Rate (2013-2018)
10 Global Hadron Therapy Market Segment by Type
10.1 Global Hadron Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hadron Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Hadron Therapy Revenue and Market Share by Type (2013-2018)
10.2 Electron Beam Sales Growth and Price
10.2.1 Global Electron Beam Sales Growth (2013-2018)
10.2.2 Global Electron Beam Price (2013-2018)
10.3 Proton Beam Sales Growth and Price
10.3.1 Global Proton Beam Sales Growth (2013-2018)
10.3.2 Global Proton Beam Price (2013-2018)
10.4 Neutron Beam Sales Growth and Price
10.4.1 Global Neutron Beam Sales Growth (2013-2018)
10.4.2 Global Neutron Beam Price (2013-2018)
10.5 Carbon Ion Beam Sales Growth and Price
10.5.1 Global Carbon Ion Beam Sales Growth (2013-2018)
10.5.2 Global Carbon Ion Beam Price (2013-2018)
10.6 Alpha Particle Beam Sales Growth and Price
10.6.1 Global Alpha Particle Beam Sales Growth (2013-2018)
10.6.2 Global Alpha Particle Beam Price (2013-2018)
10.7 Beta Particle Beam Sales Growth and Price
10.7.1 Global Beta Particle Beam Sales Growth (2013-2018)
10.7.2 Global Beta Particle Beam Price (2013-2018)
11 Global Hadron Therapy Market Segment by Application
11.1 Global Hadron Therapy Sales Market Share by Application (2013-2018)
11.2 Pediatric Cancer Sales Growth (2013-2018)
11.3 Bone and Soft Tissue Cancer Sales Growth (2013-2018)
11.4 Prostate Cancer Sales Growth (2013-2018)
11.5 Lung Cancer Sales Growth (2013-2018)
11.6 Liver Cancer Sales Growth (2013-2018)
11.7 Eye Cancer Sales Growth (2013-2018)
11.8 Head & Neck Cancer Sales Growth (2013-2018)
11.9 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) Sales Growth (2013-2018)
12 Hadron Therapy Market Forecast (2018-2023)
12.1 Global Hadron Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Hadron Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Hadron Therapy Market Forecast (2018-2023)
12.2.2 Europe Hadron Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hadron Therapy Market Forecast (2018-2023)
12.2.4 South America Hadron Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hadron Therapy Market Forecast (2018-2023)
12.3 Hadron Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Hadron Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Hadron Therapy Market Share Forecast by Type (2018-2023)
12.4 Hadron Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Hadron Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Hadron Therapy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Hadron Therapy Picture
Table Product Specifications of Hadron Therapy
Figure Global Sales Market Share of Hadron Therapy by Types in 2017
Table Hadron T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
